Children's National Medical Center in Washington DC
Home | Contact Us | Directions | Site Map
About Children's | International Program | Advocacy | Press Room | Careers
 
  For Patients and Families For Doctors and Healthcare Professionals Departments and Programs Research at Children's Education and Training
 
Tell Me More
 
 
Or find by letter: A-F  G-L  M-R  S-Z Advanced Search
 
 
   
 
Research at Children's
About CRI
Research Funding
Research Centers
Faculty
Scientific Programmatic Areas
Disorders Studied
Adherence in Juvenile Diabetes
Asthma and Lung Disease
Autism
Brain and Spinal Cord Trauma
Brain Tumors
Cancers of Childhood
Cigarette Smoking
Crib Death (SIDS)
Depression in Childhood
Diabetes
Down Syndrome
Epilepsy
Healthcare Quality and Assessment
HIV/AIDS
Inborn Errors of Metabolism
Leukodystrophy
Macular Degeneration
Medical Errors
Muscular Dystrophies
Neuro-oncology / Neurofibromatosis
Obesity and Metabolic Syndrome
Provider Patient Communication
Sickle Cell Disease
Transgender Issues
Violence Exposure Among Young Mothers
White Matter Disease
Youth Violence
Clinical Trials
Core Facilities
Support CRI
Education
Partners of CRI
 
 
Email this page Email This Page
Print this page Print This Page
 
     
 

Macular Degeneration

Age-related macular degeneration (AMD) is a progressive degenerative disease that affects the macula of elderly people (age 65 year and older), resulting in irreversible loss of vision. The disease is characterized by the accumulation of proteaneous deposits called drusen occurring between the retinal pigment epithelium (RPE) and the Bruch’s membrane. There are both dry (atrophic) and wet form (accompanied by choroidal neovascularization) of AMD. While the genetics factors implicated in the disease are becoming clear, the pathophysiology remains difficult to understand. Specifically, the connection between predisposing polymorphisms, environmental factors and the formation of the characteristic drusen are not understood. 

Secreted Protein Profiling Using Stable Isotope Labeling by Amino Acids.

Our research focuses on RPE secreted proteins and their role in drusen formation and choroidal neovascularization. Through collaboration with a clinical expert in AMD at the NEI (Karl Csaky, MD) we have established several RPE cell cultures derived from AMD donors (diagnosed by histological examinations of the macula and genotyped for the predisposing SNPs) and from age matched control donors. Our goal is to define the cellular and molecular mechanisms involved in AMD pathology. We are using Stable Isotope Labeling by Amino Acid (SILAC) strategy in combination with mass spectrometry and bioinformatics for accurate and comprehensive profiling of these RPE secreted proteins.

Our laboratory is equipped with state-of-the-art mass spectrometers (ABI 4700 MALDI TOF-TOF and a Thermo-Finnigan ESI-LTQ coupled to and nano-LC system) for high throughput comparative proteomics and structural analysis.

Related Links

American Macular Degeneration Foundation
www.macular.org

National Eye Institute
www.nei.nih.gov

Medline
www.ncbi.nlm.nih.gov


Contact Information:

Yetrib Hathout, PhD
Children’s Research Institute
Research Center for Genetic Medicine
Children's National Medical Center
111 Michigan Avenue, NW
Washington, DC 20010
202-476-3136
yhathout@cnmcresearch.org
 


   
Children's National Medical Center     |     111 Michigan Avenue, NW Washington, DC 20010     |     202-476-5000     |     © 2008 & Privacy Statement